COVID-19: Новости
Данные еще 19-го года
A meta-analysis of 18 randomised controlled trials found statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance.[931]
A systematic review and meta-analysis found that adding ivermectin to usual care led to significant clinical improvement and a significant reduction in all-cause mortality compared with usual care
A meta-analysis of six randomised controlled trials found a preliminary positive effect on mortality associated with use in hospitalised patients. The authors concluded that this effect warrants further appropriately designed, large-scale randomised controlled trials.
Но:
The European Medicines Agency does not recommend ivermectin for the treatment or prevention of COVID-19 outside of clinical trials.
The World Health Organization does not recommend ivermectin except in the context of
a clinical trial
The Infectious Diseases Society of America recommends against the use of ivermectin in outpatients and hospitalised patients outside of the context of a clinical trial
Почти за 2 года можно было провести клинические испытания, при желании...Не дают они альтернативных шансов , кроме вакцинации (на этой дудке можно играть вечно) Лечить не выгодно.
Не срубить по 15 лярдов в год.